Which agent is contraindicated in women with inflammatory bowel disease (IBD) who are considering pregnancy?

Updated: Apr 10, 2020
  • Author: William A Rowe, MD; Chief Editor: BS Anand, MD  more...
  • Print

The only agent that is contraindicated in women considering pregnancy is methotrexate (MTX), which has demonstrated teratogenic effects. MTX should be discontinued 3 months prior to planned conception.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!